Behdani, Mahdi <br/><br/>
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.  [electronic resource] 

 -  New biotechnology  Jan 2013 
 - 205-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1876-4347 
<br/><br/><label>Standard No.: </label>10.1016/j.nbt.2012.09.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP Ribose Transferases--pharmacology<br/>Bacterial Toxins--pharmacology<br/>Cell Proliferation--drug effects<br/>Chromatography, Gel<br/>Enzyme-Linked Immunosorbent Assay<br/>Exotoxins--pharmacology<br/>HEK293 Cells<br/>Humans<br/>Immunotoxins--isolation & purification<br/>Neoplasms--drug therapy<br/>Recombinant Proteins--isolation & purification<br/>Single-Domain Antibodies--therapeutic use<br/>Vascular Endothelial Growth Factor Receptor-2--immunology<br/>Virulence Factors--pharmacology<br/>Pseudomonas aeruginosa Exotoxin A